| Steven Holt Given, | |
|
Harborview Medical Center, 325 9th Ave, Seattle, WA 98104 | |
| (206) 731-4192 | |
| Not Available |
| Full Name | Steven Holt Given |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Harborview Medical Center, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457437261 | NPI | - | NPPES |
| 322880 | Other | INTERNAL ID-MOTOR VEHICLE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | AC00000716 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steven Holt Given, Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Steven Holt Given, Harborview Medical Center, 325 9th Ave, Seattle, WA 98104 Ph: (206) 731-4192 |
News Archive
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities.
Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.
Although state tax collections are picking up after several brutal years, a new survey by the National Governors Association and the National Association of State Budget Officers found that states still expect to collect less tax revenue and spend less money in the coming fiscal year than they did before the Great Recession began.
In their new paper available on the bioRxiv* preprint server, US researchers from the OpenBiome nonprofit organization used a mathematical model to simulate the usefulness of different testing strategies for fecal samples and showed that the probability of releasing a fecal microbiota donation with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is low when several important variables are taken into account.
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 4 days ago
Dr. Leandro Pasos, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 12707 30th Ave Ne, Seattle, WA 98125 Phone: 206-384-1866 Fax: 206-367-4284 | |
Jannine Krause, ND, LAC General Practice Medicare: Not Enrolled in Medicare Practice Location: 2004 Fairview Ave, Seattle, WA 98121 Phone: 206-749-0169 | |
Dr. Johanna H Vanbelle, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2150 N 122nd St, Seattle, WA 98133 Phone: 206-363-4105 Fax: 206-363-1723 | |
Dr. Joshua Mitchell Lieberman, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 7245 29th Ave Ne, Seattle, WA 98115 Phone: 206-351-3241 | |
Jennifer Bolnick, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 904 7th Ave, Seattle, WA 98104 Phone: 206-860-5404 Fax: 206-860-2295 | |
Lauren Gabrielle Scovel, MD General Practice Medicare: Medicare Enrolled Practice Location: 1455 Nw Leary Way Ste 250, Seattle, WA 98195 Phone: 206-520-5000 | |
Dr. Quan P Le, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4069 Rainier Ave S Ste A, Seattle, WA 98118 Phone: 206-721-2402 Fax: 206-725-9870 |